Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine if the administration of Tarceva™ after disease progression on standard platinum-based chemotherapy in the treatment of NSCLC results in improved overall survival when compared to Alimta® (pemetrexed) or Taxotere® (docetaxel).
Critère d'inclusion
- Advanced (stage IIIB or IV) non-small cell lung cancer (NSCLC) previously treated with a platinum-based chemotherapy